CNSX:SNN - Sunniva Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $4.93 +0.01 (+0.20 %) (As of 03/25/2019 04:00 PM ET)Previous Close$4.92Today's Range$4.90 - $5.0252-Week Range$7.05 - $16.00Volume61,558 shsAverage Volume44,398 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Sunniva Inc., through its subsidiaries, operates as a vertically integrated medical cannabis company in California and Canada. The company focuses on producing medical cannabis; and converting trim to extracted products, such as cannabis oil. It also owns and operates a network of 7 clinics in Canada specializing in medical cannabis; and provides custom, private-label vaporizers serving approximately 80 brands in the North American marketplace. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada. Receive SNN News and Ratings via Email Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange CNSX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolCNSX:SNN Previous Symbol CUSIPN/A CIKN/A Webwww.sunniva.com Phone1-866-SUNNIVADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Sunniva (CNSX:SNN) Frequently Asked Questions What is Sunniva's stock symbol? Sunniva trades on the CNSX under the ticker symbol "SNN." What price target have analysts set for SNN? 2 equities research analysts have issued 1-year target prices for Sunniva's shares. Their predictions range from $13.00 to $39.49. On average, they anticipate Sunniva's share price to reach $26.2450 in the next twelve months. This suggests a possible upside of 432.4% from the stock's current price. View Analyst Price Targets for Sunniva. What is the consensus analysts' recommendation for Sunniva? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sunniva in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sunniva. Has Sunniva been receiving favorable news coverage? Media headlines about SNN stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Sunniva earned a news impact score of -1.1 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. Who are some of Sunniva's key competitors? Some companies that are related to Sunniva include Activecare (ACAR), Airware Labs (AIRW), Cannabix Technologies (BLOZF), Cannabix Technologies (BLO), COCHLEAR LTD/ADR (CHEOY), Ellex Medical Lasers (ELXMF), GN Store Nord A/S (GGNDF), MRI Interventions (MRIC), Neuroone Medical Technologies (NMTC), PetVivo (PETV), Quadron Cannatech (QCC), Rafina Innovations (VICA), Sartorius Stedim Biotech (DIM), Viemed Healthcare (VMD) and Vycor Medical (VYCO). What other stocks do shareholders of Sunniva own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sunniva investors own include Canopy Growth (WEED), Cronos Group (CRON), Energous (WATT), Canopy Growth (CGC), Aurora Cannabis (ACB), Aphria (APHA), Aurora Cannabis (ACB), OrganiGram (OGI), CannTrust (CTST) and CanniMed (CMED). Who are Sunniva's key executives? Sunniva's management team includes the folowing people: Dr. Anthony F. Holler, Co-founder, CEO & Chairman (Age 67)Mr. Leith Pedersen, Founder, Pres, Chief Strategy Officer & Director (Age 47)Mr. Duncan Gordon, Chief Operating Officer (Age 55)Mr. David Negus C.A., CPA, Chief Financial Officer (Age 52)Mr. Benjamin Rootman, Gen. Counsel & Corp. Sec. (Age 41) How do I buy shares of Sunniva? Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Sunniva's stock price today? One share of SNN stock can currently be purchased for approximately $4.93. What is Sunniva's official website? The official website for Sunniva is https://www.sunniva.com/. How can I contact Sunniva? Sunniva's mailing address is Suite 400, 355 – 4th Avenue S.W. Calgary, AB T2P 0J1. The company can be reached via phone at 1-866-SUNNIVA. MarketBeat Community Rating for Sunniva (CNSX SNN)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 43 (Vote Outperform)Underperform Votes: 32 (Vote Underperform)Total Votes: 75MarketBeat's community ratings are surveys of what our community members think about Sunniva and other stocks. Vote "Outperform" if you believe SNN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/25/2019 by MarketBeat.com StaffFeatured Article: Why is cost of goods sold important?